Arnold & Porter LLP represented The Charles Schwab Corporation in the sale of $425 million of depositary shares, each representing a 1/40th ownership interest in a share of 6.00% Non-Cumulative Perpetual Preferred Stock, Series B. The deal closed June 6, 2012.
Tags: Arnold & Porter Kaye Scholer LLPCooley Achieves $250 Million Tax Victory for Entergy
Cooley LLP announced an important litigation victory for Cooley client Entergy Corporation. The Fifth Circuit ruled in favor of Entergy’s claim for almost $250 million in foreign tax credits for the UK “windfall tax,” a tax on companies in regulated industries that were privatized by the UK. The victory was the product of close collaboration between Entergy’s Tax Counsel and the Cooley tax litigation team. The victory was achieved despite a recent adverse Third Circuit ruling (not involving Cooley) on the same tax.
Tags: Cooley LLP | New YorkDLA Piper Continues Expansion of Corporate and Insurance Practices with Addition of David Luce in New York
DLA Piper announced today that David Luce has joined the firm’s Corporate and Finance practice and Insurance and Reinsurance Sector practice as a partner in New York.
Tags: DLA Piper | New YorkHogan Lovells Advises LabCorp on Proposed US$240 Million Acquisition of MEDTOX Scientific
Hogan Lovells announced today that a team of its corporate and transactional lawyers are advising client Laboratory Corporation of America Holdings (LabCorp) on LabCorp’s proposed acquisition of MEDTOX Scientific, Inc. (NASDAQ: MTOX) in a cash merger having a value of approximately US$240 million. LabCorp is an S&P 500 company headquartered in Burlington, NC and operates one of the largest clinical laboratory networks in the world, with a U.S. network of 36 primary laboratories. MEDTOX Scientific offers a variety of laboratory services and devices geared towards the detection of drug and alcohol use.
Tags: Hogan LovellsWhite & Case Advises China Development Bank on US$750 Million Committed Financing for Solar Power Projects in the USA
Global law firm White & Case LLP has advised China Development Bank (CDB) on its commitment of up to US$750 million to fund the procurement, construction, installation and operation of solar power projects in New Jersey, USA with a total installed capacity of up to 300MW. The financing comprises both secured EPC financing to be provided to SPI Solar and secured long-term financing to be provided to KDC Solar.
Tags: White & Case LLP | Hong KongWhite & Case Strengthens Project Finance Team
Global law firm White & Case LLP is strengthening its Global Project Finance capabilities in Düsseldorf, Germany, with the addition of Dr. Jan-Holger Arndt as partner. Dr. Arndt will focus on advising financial investors, primarily in conjunction with German and international project finance and asset finance transactions. He will also advise on restructurings.
Tags: White & Case LLPSedgwick Seattle Welcomes Partner Barry Mesher
Barry Mesher, formerly of Lane Powell PC, has joined the firm’s Seattle office as part of the Complex Litigation Division.
Tags: Sedgwick LLPAkin Gump Advises Gushan Environmental Energy Limited on Merger and Take-Private Agreement
A team of Akin Gump attorneys has been retained by a special committee of Chinese copper products manufacturer and producer of biodiesel Gushan Environmental Energy Limited in its agreement to merge with Trillion Energy Holdings Limited and Trillion Energy Investments Holdings Limited. Trillion Energy Holdings Limited is wholly owned by Gushan’s chairman and principal executive officer, Jianqiu Yu. He also currently owns 34.8 percent of Gushan’s issued and outstanding ordinary shares.
Tags: Akin Gump Strauss Hauer & Feld LLP | Hong KongChadbourne Represents WAMEX Private Equity In The Formation Of Mexican Growth Equity Fund
Chadbourne represented WAMEX Private Equity Management L.L.C. on the formation of Multinational Industrial Fund II, L.P., which held its final closing in March 2012. The fund represents the second private equity fund raised by WAMEX, and was formed to make growth equity investments in a broad spectrum of sectors throughout Mexico.
Tags: New YorkPaul Hastings Advises BioMarin Pharmaceutical Inc. in Follow-On Public Offering
Paul Hastings LLP, a leading global law firm, announced today that the firm advised BioMarin Pharmaceutical Inc., a pharmaceutical company that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, in connection with its underwritten offering of 6,500,000 shares of common stock. In connection with launching the offering BioMarin estimated the offering would raise gross proceeds of approximately $249 million before costs.
Tags: Paul Hastings, LLP







